TrialCNS drugs2026

Efficacy and Safety of Solriamfetol on Excessive Daytime Sleepiness Associated with Obstructive Sleep Apnea in China: A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial.

Hanrong Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.